{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:28:53Z","timestamp":1792790933721,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Special Project for Health Talents of Jilin Provincial Department of Finance","award":["JLSWSRCZX2021-071"],"award-info":[{"award-number":["JLSWSRCZX2021-071"]}],"id":[{"id":"https:\/\/ror.org\/05rjrj969","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Doctor of excellence program (DEP), The First Hospital of Jilin University","award":["JDYY-DEP-2023028"],"award-info":[{"award-number":["JDYY-DEP-2023028"]}],"id":[{"id":"https:\/\/ror.org\/034haf133","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Youth Development Foundation of the First Hospital of Jilin University","award":["JDYY15202401"],"award-info":[{"award-number":["JDYY15202401"]}],"id":[{"id":"https:\/\/ror.org\/034haf133","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81903-z","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T16:01:26Z","timestamp":1733241686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Exploring the dark side of diagnostic dyes with a focus on Indocyanine green\u2019s adverse reactions"],"prefix":"10.1038","volume":"14","author":[{"given":"Yan","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"81903_CR1","doi-asserted-by":"publisher","first-page":"7823","DOI":"10.2147\/IJN.S207486","volume":"14","author":"C Egloff-Juras","year":"2019","unstructured":"Egloff-Juras, C., Bezdetnaya, L., Dolivet, G. & Lassalle, H. P. NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green. Int. J. Nanomed. 14, 7823\u20137838. https:\/\/doi.org\/10.2147\/IJN.S207486 (2019).","journal-title":"Int. J. Nanomed."},{"key":"81903_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrclinonc.2013.123","volume":"10","author":"AL Vahrmeijer","year":"2013","unstructured":"Vahrmeijer, A. L., Hutteman, M., van der Vorst, J. R., van de Velde, C. J. & Frangioni, J. V. Image-guided cancer surgery using near-infrared fluorescence. Nat. Rev. Clin. Oncol. 10, 507\u2013518. https:\/\/doi.org\/10.1038\/nrclinonc.2013.123 (2013).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"81903_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/jamasurg.2019.6033","volume":"155","author":"QY Chen","year":"2020","unstructured":"Chen, Q. Y. et al. Safety and Efficacy of Indocyanine Green Tracer-guided lymph node dissection during laparoscopic radical gastrectomy in patients with gastric Cancer: a Randomized Clinical Trial. JAMA Surg. 155, 300\u2013311. https:\/\/doi.org\/10.1001\/jamasurg.2019.6033 (2020).","journal-title":"JAMA Surg."},{"key":"81903_CR4","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/SLA.0000000000006242","volume":"279","author":"ZN Huang","year":"2024","unstructured":"Huang, Z. N. et al. Assessment of Laparoscopic Indocyanine Green Tracer-guided Lymphadenectomy after Neoadjuvant Chemotherapy for locally advanced gastric Cancer: a Randomized Controlled Trial. Ann. Surg. 279, 923\u2013931. https:\/\/doi.org\/10.1097\/SLA.0000000000006242 (2024).","journal-title":"Ann. Surg."},{"key":"81903_CR5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/SLA.0000000000005406","volume":"275","author":"T Wakabayashi","year":"2022","unstructured":"Wakabayashi, T. et al. Indocyanine Green Fluorescence Navigation in Liver surgery: a systematic review on dose and timing of Administration. Ann. Surg. 275, 1025\u20131034. https:\/\/doi.org\/10.1097\/SLA.0000000000005406 (2022).","journal-title":"Ann. Surg."},{"key":"81903_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/SLA.0000000000004718","volume":"274","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Consensus guidelines for the use of fluorescence imaging in hepatobiliary surgery. Ann. Surg. 274, 97\u2013106. https:\/\/doi.org\/10.1097\/SLA.0000000000004718 (2021).","journal-title":"Ann. Surg."},{"key":"81903_CR7","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal, A. G. et al. AASLD Practice Guidance on Prevention, diagnosis, and Treatment of Hepatocellular Carcinoma. Hepatology 78, 1922\u20131965. https:\/\/doi.org\/10.1097\/HEP.0000000000000466 (2023).","journal-title":"Hepatology"},{"key":"81903_CR8","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1038\/s41598-019-44815-x","volume":"9","author":"C Schwarz","year":"2019","unstructured":"Schwarz, C. et al. The value of indocyanine green clearance assessment to predict postoperative liver dysfunction in patients undergoing liver resection. Sci. Rep. 9, 8421. https:\/\/doi.org\/10.1038\/s41598-019-44815-x (2019).","journal-title":"Sci. Rep."},{"key":"81903_CR9","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1038\/s41467-023-42712-6","volume":"14","author":"QY Chen","year":"2023","unstructured":"Chen, Q. Y. et al. Indocyanine green fluorescence imaging-guided versus conventional laparoscopic lymphadenectomy for gastric cancer: long-term outcomes of a phase 3 randomised clinical trial. Nat. Commun. 14, 7413. https:\/\/doi.org\/10.1038\/s41467-023-42712-6 (2023).","journal-title":"Nat. Commun."},{"key":"81903_CR10","doi-asserted-by":"publisher","first-page":"106120","DOI":"10.1016\/j.ijsu.2021.106120","volume":"94","author":"Q Zhong","year":"2021","unstructured":"Zhong, Q. et al. Clinical implications of indocyanine green fluorescence imaging-guided laparoscopic lymphadenectomy for patients with gastric cancer: a cohort study from two randomized, controlled trials using individual patient data. Int. J. Surg. 94, 106120. https:\/\/doi.org\/10.1016\/j.ijsu.2021.106120 (2021).","journal-title":"Int. J. Surg."},{"key":"81903_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jaccao.2019.10.006","volume":"1","author":"K Anand","year":"2019","unstructured":"Anand, K., Ensor, J., Trachtenberg, B. & Bernicker, E. H. Osimertinib-Induced cardiotoxicity: a retrospective review of the FDA adverse events reporting System (FAERS). JACC CardioOncol. 1, 172\u2013178. https:\/\/doi.org\/10.1016\/j.jaccao.2019.10.006 (2019).","journal-title":"JACC CardioOncol"},{"key":"81903_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jaad.2023.05.041","volume":"89","author":"D Arcuri","year":"2023","unstructured":"Arcuri, D., Kaouache, M., Lagace, F., Sasseville, D. & Litvinov, I. A case-control pharmacovigilance study of TNF-alpha inhibitors and interleukin inhibitors on tuberculosis, Candida, lymphoma and suicidality using the FAERS database (2014\u20132020). J. Am. Acad. Dermatol. 89, 619\u2013621. https:\/\/doi.org\/10.1016\/j.jaad.2023.05.041 (2023).","journal-title":"J. Am. Acad. Dermatol."},{"key":"81903_CR13","doi-asserted-by":"publisher","unstructured":"Zhou, C. et al. Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database. EClinicalMedicine 59, 101967. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101967 (2023)","DOI":"10.1016\/j.eclinm.2023.101967"},{"key":"81903_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2165\/00002018-200427080-00010","volume":"27","author":"EG Brown","year":"2004","unstructured":"Brown, E. G. Using MedDRA: implications for risk management. Drug Saf. 27, 591\u2013602. https:\/\/doi.org\/10.2165\/00002018-200427080-00010 (2004).","journal-title":"Drug Saf."},{"key":"81903_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman, K. J., Lanes, S. & Sacks, S. T. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 13, 519\u2013523. https:\/\/doi.org\/10.1002\/pds.1001 (2004).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"81903_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"EP van Puijenbroek","year":"2002","unstructured":"van Puijenbroek, E. P. et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 11, 3\u201310. https:\/\/doi.org\/10.1002\/pds.668 (2002).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"81903_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans, S. J., Waller, P. C. & Davis, S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 10, 483\u2013486. https:\/\/doi.org\/10.1002\/pds.677 (2001).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"81903_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate, A. et al. A bayesian neural network method for adverse drug reaction signal generation. Eur. J. Clin. Pharmacol. 54, 315\u2013321. https:\/\/doi.org\/10.1007\/s002280050466 (1998).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"81903_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","volume":"25","author":"A Szarfman","year":"2002","unstructured":"Szarfman, A., Machado, S. G. & O\u2019Neill, R. T. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA\u2019s spontaneous reports database. Drug Saf. 25, 381\u2013392. https:\/\/doi.org\/10.2165\/00002018-200225060-00001 (2002).","journal-title":"Drug Saf."},{"key":"81903_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.2165\/00002018-200629100-00005","volume":"29","author":"JS Almenoff","year":"2006","unstructured":"Almenoff, J. S., LaCroix, K. K., Yuen, N. A., Fram, D. & DuMouchel, W. Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department. Drug Saf. 29, 875\u2013887. https:\/\/doi.org\/10.2165\/00002018-200629100-00005 (2006).","journal-title":"Drug Saf."},{"key":"81903_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jcpt.13024","volume":"45","author":"S Kinoshita","year":"2020","unstructured":"Kinoshita, S., Hosomi, K., Yokoyama, S. & Takada, M. Time-to-onset analysis of amiodarone-associated thyroid dysfunction. J. Clin. Pharm. Ther. 45, 65\u201371. https:\/\/doi.org\/10.1111\/jcpt.13024 (2020).","journal-title":"J. Clin. Pharm. Ther."},{"key":"81903_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpedsurg.2022.09.020","volume":"58","author":"A Le-Nguyen","year":"2023","unstructured":"Le-Nguyen, A. et al. Indocyanine green fluorescence angiography in pediatric intestinal resections: a first prospective mixed methods clinical trial. J. Pediatr. Surg. 58, 82\u201388. https:\/\/doi.org\/10.1016\/j.jpedsurg.2022.09.020 (2023).","journal-title":"J. Pediatr. Surg."},{"key":"81903_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.4240\/wjgs.v15.i5.757","volume":"15","author":"H Abdelrahman","year":"2023","unstructured":"Abdelrahman, H., El-Menyar, A., Peralta, R. & Al-Thani, H. Application of indocyanine green in surgery: a review of current evidence and implementation in trauma patients. World J. Gastrointest. Surg. 15, 757\u2013775. https:\/\/doi.org\/10.4240\/wjgs.v15.i5.757 (2023).","journal-title":"World J. Gastrointest. Surg."},{"key":"81903_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40264-024-01421-9","volume":"47","author":"M Fusaroli","year":"2024","unstructured":"Fusaroli, M. et al. The reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement. Drug Saf. 47, 575\u2013584. https:\/\/doi.org\/10.1007\/s40264-024-01421-9 (2024).","journal-title":"Drug Saf."},{"key":"81903_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40264-024-01423-7","volume":"47","author":"M Fusaroli","year":"2024","unstructured":"Fusaroli, M. et al. The REporting of a disproportionality analysis for DrUg Safety Signal Detection using individual Case Safety reports in PharmacoVigilance (READUS-PV): explanation and elaboration. Drug Saf. 47, 585\u2013599. https:\/\/doi.org\/10.1007\/s40264-024-01423-7 (2024).","journal-title":"Drug Saf."},{"key":"81903_CR26","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/all.14580","volume":"76","author":"D de Silva","year":"2021","unstructured":"de Silva, D. et al. Diagnosing, managing and preventing anaphylaxis: systematic review. Allergy 76, 1493\u20131506. https:\/\/doi.org\/10.1111\/all.14580 (2021).","journal-title":"Allergy"},{"key":"81903_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/all.15032","volume":"77","author":"A Muraro","year":"2022","unstructured":"Muraro, A. et al. EAACI guidelines: Anaphylaxis (2021 update). Allergy 77, 357\u2013377. https:\/\/doi.org\/10.1111\/all.15032 (2022).","journal-title":"Allergy"},{"key":"81903_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.wneu.2019.09.135","volume":"133","author":"M Kim","year":"2020","unstructured":"Kim, M. et al. Anaphylactic shock after Indocyanine Green Video Angiography during cerebrovascular surgery. World Neurosurg. 133, 74\u201379. https:\/\/doi.org\/10.1016\/j.wneu.2019.09.135 (2020).","journal-title":"World Neurosurg."},{"key":"81903_CR29","doi-asserted-by":"publisher","first-page":"6407","DOI":"10.1177\/00031348231206584","volume":"89","author":"NB Keller","year":"2023","unstructured":"Keller, N. B., Stapler, S. M., Shanker, B. A. & Cleary, R. K. Anaphylactic shock to Intravenous Indocyanine Green during a robotic right colectomy. Am. Surg. 89, 6407\u20136409. https:\/\/doi.org\/10.1177\/00031348231206584 (2023).","journal-title":"Am. Surg."},{"key":"81903_CR30","doi-asserted-by":"publisher","unstructured":"Juraschek, S. P. et al. Orthostatic hypotension, dizziness, neurology outcomes, and death in older adults. Neurology 95, e1941-e1950, (2020). https:\/\/doi.org\/10.1212\/WNL.0000000000010456","DOI":"10.1212\/WNL.0000000000010456"},{"key":"81903_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/ACC.0b013e3182933c12","volume":"1","author":"J Bjerregaard","year":"2013","unstructured":"Bjerregaard, J., Pandia, M. P. & Jaffe, R. A. Occurrence of severe hypotension after indocyanine green injection during the intraoperative period. Case Rep. 1, 26\u201330. https:\/\/doi.org\/10.1097\/ACC.0b013e3182933c12 (2013).","journal-title":"Case Rep."},{"key":"81903_CR32","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ijwd.2021.03.006","volume":"7","author":"KN Price","year":"2021","unstructured":"Price, K. N., Grinnell, M., Butler, D. & Shah, A. Art of prevention: practical tips for improving adherence to treatments for older patients in dermatology. Int. J. Womens Dermatol. 7, 478\u2013481. https:\/\/doi.org\/10.1016\/j.ijwd.2021.03.006 (2021).","journal-title":"Int. J. Womens Dermatol."},{"key":"81903_CR33","doi-asserted-by":"publisher","unstructured":"Kvarnstrom, K., Westerholm, A., Airaksinen, M. & Liira, H. Factors contributing to Medication Adherence in patients with a Chronic Condition: a scoping review of qualitative research. Pharmaceutics 13, 1100. https:\/\/doi.org\/10.3390\/pharmaceutics13071100 (2021).","DOI":"10.3390\/pharmaceutics13071100"},{"key":"81903_CR34","unstructured":"Muraleedharan, S. & Tripathy, K. Indocyanine Green (ICG) Angiography. in StatPearls. (2024)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81903-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81903-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81903-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T16:15:38Z","timestamp":1733242538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81903-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81903"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81903-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The FAERS database, utilized for this research, is publicly accessible through the FDA\u2019s official website. The datasets used and analyzed during the current study are available from the corresponding author upon reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data sharing statement"}},{"value":"No ethical approval is required for studies using publicly available data from FAERS.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"30155"}}